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ORIGINAL ARTICLE

Antidiabetic evaluation of Hemionitis arifolia
leaves by in vitro methods
Krishna Kumar K R1*, Jayaprakash A P3 and Srinivasan K K3
1) University College of Pharmacy, M G University, Cheruvandoor, Ettumanoor-686 631, Kottayam, Kerala, India.
2) University College of Pharmacy, M G University, RIMSR, Kottayam
3) Shri Madhwa Vadiraja Institute of Technology, Vishwothama Nagar, Bantakal, Udupi, Karnataka, India.

ABSTRACT
In the present article, antidiabetic activity of the extracts of H. arifolia leaves prepared with 95% ethanol (HALE) and
50% ethanol (HALH) were evaluated by various in vitro methods. Initially, preliminary phytochemical studies were
performed and the presence of phenolic, flavonoids and their glycosides were identified. In the antidiabetic activity
evaluation enzyme inhibition and glucose uptake studies on muscle cell lines were performed. In the enzyme inhibition
studies, models such as alpha amylase inhibition and DPP-IV inhibition assays were performed. In the alpha amylase
inhibition studies IC50 values of HALE and HALH were found to be above 1000 μg/ml. In the DPP-IV inhibition
studies, the IC50 value was found to be above 500 μg/ml. HALH exhibited only 15.83% inhibition of DPP-IV at a
concentration of 500 μg/ml. Glucose uptake studies and the mechanism of action identification were performed
on L-6 muscle cell lines of rats. HALH demonstrated better glucose uptake (26.0±0.22% over control) compared
to HALE glucose uptake values (14.0±4.17% over control) in the experiment. In the evaluation of mechanism of
action of glucose transport by HALH on L-6 cell lines, Glut-4 upregulation and PPARγ upregulation were observed.
Glut-4 gene upregulation of 0.15 and 0.09 fold over normal control were demonstrated by HALH at a concentration
of 500 and 250 μg/ml, respectively. In the other mechanism of action identified of glucose transport by HALH on
L-6 cell lines, 0.20 and 0.15 fold upregulation of PPARγ genes over normal at a concentration of 500 and 250 μg/ml
concentration were also observed. In the MTT assay studies, CTC50 values of both the extracts were found to be above
1000 μg/ml. The above all data are indicative of the antidiabetic potential of H. arifolia leaves.
Key words: Hemionitis arifolia, leaf extract preparation; Phytochemistry; alpha amylase inhibition studies; DPP-IV
inhibition studies; glucose uptake studies on L-6 muscle cell lines; Glut-4 translocation; PPARγ upregulation; MTT
assay; antidiabetic evaluation
INTRODUCTION
Antidiabetic activity is one among the acclaimed properties
of H. arifolia in folk medicine of Kerala. Later studies on
various other plants revealed the relation between the
antioxidant property and the presence of phytoconstituents
such as phenolics, flavonoids and phytosterols1. In the
phytochemical analysis of H. arifolia leaf extract in ethanol,
presence of phenolics and flavonoids were detected and
quantified2,3. The reported components are apigenin,
kaempferol, quercetin and some of its glycosides such as
rutin.
In diabetes mellitus, NOS (iNOS (inducible NOS) over
expression causes the destruction of β-cells of pancreas
* For Correspondence:
E-mail: krishnakumar_kr@yahoo.co.in

by inhibition of mitochondrial enzymes and via different
cytokines released from activated lymphocytes4. Peroxynitrile
(ONOO-) which is another powerful antioxidant causes
tyrosine nitration, thiol oxidation, lipid peroxidation, DNA
strand break, guanosine nitration/oxidation and ultimately
cell death. When, the overall generation of ROS and RNS
exceeds the total antioxidant activity in the body, oxidative
stress will develop. Antioxidants prevent free radical induced
tissue damage by preventing the formation of radicals,
scavenging them, or by promoting their decomposition5.
Antioxidant studies of both the extracts were performed by
ABTS, DPPH, nitric oxide scavenging and lipid peroxidation
inhibition methods and the results were promising and were
reported6. In this case, it is important to observe the nitric
oxide scavenging activity demonstrated by the extracts.
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Here, it can be correlated with the above cited reports of
Young I S and Wood side J V5. In the studies performed
on Wistar albino rats using alcoholic extract, antidiabetic
activity was reported.7 During the collection of plants, first
author personally observed the interest of village goats/
sheeps to eat H. arifolia. The above all points motivated us
to investigate further to find and evaluate the methods by
which the acclaimed antidiabetic activity works out in both
the extracts and the components identified and reported.

Extracts of H. arifolia leaf was prepared according to
reported procedure2 and, pure quercetin and rutin were used
for the studies. Ethanol 95% extract was named as HALE
and ethanol 50% extract was named HALH. The plant was
identified by Dr K V George, Professor of Botany, CMS
College, Kottayam and the voucher specimen number is
KRK/UCP/CMS/506.
Alpha amylase inhibition studies
Chemicals and reagents
Alpha amylase: 2 mg/ml in sterile water prepared using alpha
amylase enzyme (Himedia Rm 638), E.C.No. 3.2.1.1, 1:2000
IU, Phosphate buffer (pH-6.9), Starch solution 1% w/v,
Dinitrosalicylic acid reagent: Dinitrosalicylic acid (1gm) and
sodium hydroxide (12 gm) dissolved in distilled water (100
ml), DMSO.
Plates used:
Micro-well plate: Tarson 96 well polystyrene, non-treated
(Cat. no. T941196, Tarsons, India)
Preparation of the test solutions
Extracts HALE, HALH, quercetin, rutin and acarbose (10
mg each) were weighed accurately and separately dissolved
in distilled DMSO (1 ml) and respective 10 mg/ml stock
solutions were prepared. Serial dilutions of the above
stock solutions were done with DMSO to get the required
concentrations for enzyme inhibition studies.
Procedure
Bernfeld method with modifications was used in the in
vitro alpha amylase inhibition studies8. The test solutions of
extract and individual components (100 μl in DMSO) were
allowed to react with 200 μl of α-amylase enzyme according
to the standard procedure. After completion of the reaction
200 μl each of the solutions were taken in the wells of a
micro-titer plate and the absorbance was measured at 540
14

Inhibition (%) =

control − test
x 100
control

Respective reagent blank and controls were also prepared
simultaneously and used in the study. All the experiments
were performed thrice. Results are as shown in Fig.1, Fig.2
and Fig. 3.
DPP-IV inhibition studies

MATERIALS AND METHODS
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nm using a micro-plate reader. The percentage inhibition of
alpha amylase enzyme was calculated using the formula:

Chemicals and Reagents
Enzyme: Dipeptidyl aminopeptidase (EC. 3.4.14.5) IV from
porcine kidney [D7052, Sigma, USA], Substrate: Gly-Prop-nitroanilide hydrochloride [G0513, Sigma, USA], Positive
control: Ile-Pro-Ile [I9759, Sigma, USA], Trizma base
[T6066, Sigma, USA], Tris-hydrochloride [RM613, Himedia,
India], Tris HCl buffer – pH 8.2, Sodium acetate buffer 1M
(pH-4.0), DPP-IV enzyme solution 0.01 u/ml in Tris HCl
buffer – pH 8.2, Gly-Pro-p-nitroanilide hydrochloride 1.59
mM in Tris HCl buffer – pH 8.2.
Micro-titer plates:
Costar 384 well polystyrene, non-treated. (Cat. no. 3702,
Corning)
Preparation of test solutions
The standard and sample extract were dissolved in DMSO
(62.5μl) and the volume was then made up to 2 ml with
50 mM Tris buffer (pH 7.5) to get 1mg/ml solutions. The
required dilutions were prepared from the stock solution by
diluting with DMSO.
Defatted HALH extract dilutions were prepared in the same
manner as mentioned above.
Procedure
This study was performed as per the method of Kojima et
al., with some modifications9. Serially diluted test extract
and individual components (25 μl) in Tris HCl buffer (pH8.2), DPP-IV enzyme-0.01 U/ml (50 μl), prepared in Tris
HCl buffer, were taken in the wells of a 96 well microtiter plate, mixed and performed the assay as per the
standard procedure. After completion of the reaction, the
absorbance was measured at 405 nm using a micro-plate
reader (PHERAstar, BMG LABTECH, Germany). Controls
were run without test samples. Respective sample blank and
control blank were done with all reagents except the enzyme.
The experiment was done in triplicate.
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The % inhibition was calculated as follows:
% inhibition =

Absorbance (control) - Absorbance (test)
x 100
Absorbance (control)

Log- probit analysis was used to calculate IC50 values. The
results are depicted in table 1.
Materials and methods for cell line studies
Phosphate Buffered Saline (PBS), 3-(4, 5–dimethyl thiazol–2–
yl)–5–diphenyl tetrazolium bromide (MTT), Fetal Bovine
serum (FBS), Bovine Serum Albumin (BSA), D- glucose,
Dulbecco’s Modified Eagle’s Medium (DMEM) and Trypsin
were obtained from Sigma Aldrich Co., St Louis, USA.
EDTA, antibiotics and other chemicals were procured from
Hi-Media Laboratories Ltd, Mumbai. Insulin from (Torrent
Pharmaceuticals, 40 IU/ml) Dimethyl Sulfoxide (DMSO)
and Propanol from E.Merck Ltd, Mumbai, India. Membrane
filter (Millipore, 0.22μm, 047 mm (dia.) and filtration
assembly.
(Respective reagents were used from the above prepared
reagents for the various cell line studies performed as per
the requirement.)
Culturing of L-6 cells (Myoblast)
Muscle cell lines, L-6 (Rat, skeletal muscle) were procured
from National Centre for Cell Sciences (NCCS), Pune, India.
Stock cells of L-6 were cultured in DMEM supplemented
with 10% inactivated Fetal Bovine Serum (FBS), as per the
standard procedure of NCCS in 25 cm2 culture flasks. All
experiments were carried out in 96 well micro-titer plates
(Tarsons India Pvt Ltd, Kolkata, India).
Preparation of test solutions
The test extracts were separately dissolved in distilled DMSO
and the volume was made up with DMEM supplemented
with 2% inactivated FBS to obtain a stock solution of 1
mg/ml concentration and sterilized by filtration. Serial
two fold dilutions of the test extracts were prepared from
their respective stock solutions for carrying out cytotoxic
and glucose uptake studies. Similarly, the standard was also
prepared.
MTT assay- Procedure
The monolayer cell culture was trypsinized and the cell count
was adjusted to 1.5 x 104 cells/ml using DMEM containing
10% FBS. The diluted cell suspension (0.1ml) containing
approximately 1500 cells were added to each well of the

96 well micro titer plates. After 24 hours, when a partial
monolayer of 70% confluency is formed, the supernatant
was flicked off, and the monolayer was washed with medium.
The serially diluted different dilutions (100 μl) of both
the test and standard drugs were added on to the partial
monolayer formed in designated wells of the micro-titer
plates and performed the experiment as per the procedure of
Mosmann T et al., with necessary modifications10. A microplate reader was used to measure the absorbance at 540 nm.
The percentage growth inhibition was calculated using the
following formula and concentrations of test drug needed to
inhibit cell growth by 50%, (CTC50 values) were determined
from the dose-response curves for the respective extract.

Results are depicted in Fig.4
Glucose uptake studies (In vitro) on L-6 muscle cell
lines-Procedure
Among the cell lines used in glucose uptake studies L-6
skeletal muscle cell lines derived from rat skeletal muscle
is most frequently utilized as a cellular model system for
investigating the insulin-stimulated glucose transport
system11. The 24 hour cell cultures with 70-80% confluency
in 40mm petri plates were allowed to differentiate by
maintaining in DMEM with 2% FBS for 4-6 days. The
differentiated cells were serum starved over-night at the time
of experiment. Cells were washed with HEPES buffered
KRP buffer once and incubated with KRP buffer with 0.1%
BSA for 30 minutes at 37°C. Cells were treated with serially
diluted concentrations of test extract and standard drug
(metformin), for 30 minutes along with normal controls at
37 °C. D-glucose solution (20 μl) was added simultaneously
to each well and incubated at 37°C for another 30 minutes.
After incubation, the uptake of the glucose was stopped by
aspiration of solutions from wells and washed three times
with ice-cold KRP buffer solution. Then, the cells were
lysed with 0.1M NaOH solution and the cell-associated
glucose was measured using the respective aliquots of the
lysed cells. Glucose assay kit (Biovision Inc, USA) was used
to measure the glucose level in cell lysates. The experiments
were performed in triplicate and the values were used to
determine the glucose uptake percentage enhancement over
controls.
Results are depicted in Table 2.
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Materials and methods for the evaluation of mechanism
of action
GLUT-4 gene expression studies
RT-PCR Procedure
The mRNA expression levels of Glut-4 was carried out
using semi-quantitative reverse transcriptase-polymerase
chain reaction (RT-PCR). The L-6 cells were cultured in 60
mm petridish and maintained in DMEM medium for 48
hours. The DMEM medium was supplemented with FBS
and amphotericin. The serially diluted concentration of
test samples and standard were added to the petridish and
incubated for 20 minutes. Isolation of the total cellular RNA
from the untreated (control) and treated cells were performed
according to manufacturer’s protocol using Trizol reagent.
The cDNA was synthesized from the isolated total RNA
by a reverse trancriptase kit according to the manufacturer’s
instructions (Thermo scientific). The mRNA expression
levels of Glut-4 were determined by a PCR reaction using the
specific primers and constructed cDNA. The primers used
in this study were chosen as per the earlier literature12 and the
specifically designed primers procured from Eurofins India.
The expression levels of mRNA of a house keeping gene
(GAPDH) were used as an internal control.
Amplification conditions for Glut-4 gene
After the initial DNA synthesis for 30 minutes, denaturation
was done at 95 °C for 1 minute followed by 35 cycles of
denaturation at 95°C for 15 seconds, annealing at 66 °C for
30 seconds and an extension at 72 °C for 45 seconds was
done. This was followed by a final extension at 72°C for 10
minutes.

relative sample expression levels were calculated using
Alpha View, version 3.3.1.0 Cell Biosciences, Inc and were
expressed relative to GAPDH and corrected for, between
run variability. Results are depicted in Fig. 5, Fig. 6 and Table
3.
Gamma PPAR gene expression studies
RT-PCR Procedure
The mRNA expression levels of PPARγ was carried out
using semi-quantitative Reverse Transcriptase-Polymerase
Chain Reaction (RT-PCR) as explained with GLUT-4 gene
amplification studies.
The mRNA expression levels of PPARγ were determined by
a PCR reaction using the specific primers and constructed
cDNA. The primers used in this study were chosen as per
the earlier literature12 and the specifically designed primers
procured from Eurofins India.
Amplification conditions for PPARγ gene
After the initial DNA synthesis for 30 minutes, denaturation
was done at 95 °C for 1 minute followed by 35 cycles of
denaturation at 95 °C for 15 seconds, annealing at 64 °C
for 30 seconds and extension at 72 °C for 45 seconds was
done. This was followed by a final extension at 72°C for 10
minutes.
Primer used:
For I strand synthesis:

For II strand synthesis: 5’ GGA TTC ATG ACC AGG
GAG TTC CTC 3’–Forward
5’ GCG GTC TCC ACT GAG
AAT AAT GAC 3’- Reverse

Primer used:
For I strand synthesis:

Random primer

Product size:

For II strand synthesis: 5’CGG GAC GTG GAG CTG
GCC GAG GAG 3’–Forward

Product size:

Random primer

155 bp.

Analysis of amplified sequences

5’ CCC CCT CAG CAG CGA
GTG A 3’- Reverse

After PCR, the amplified samples were analyzed in the same
procedure followed for Glut-4 analysis. Results are depicted
in Fig. 7, Fig. 8 and Table 4.			

318 bp.

RESULTS

Analysis of amplified sequences
After PCR, the amplified samples were analysed through
electrophoresis in 1.8% agarose gels stained with ethidium
bromide (0.5μg/ml). The gel was scanned with ultraviolet
illumination using digital imaging (UV Tech, UK) and
16
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Both the extracts HALE and HALH were found to inhibit
alpha amylase activity at a concentration of 1000 μg/ml
and above. The pure component quercetin showed alpha
amylase inhibition and the IC50 value was 931±9.28 μg/ml
and its glycoside rutin showed IC50 value above 2000 μg/
ml concentration only. Therapeutically using antidiabetic
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acarbose showed alpha amylase inhibition and the IC50 value
was 82.0±0.85 μg/ml.

Fig. 4 MTT assay of HALE and HALH

Fig.1 Alpha amylase inhibition activity of HALE and HALH

Fig. 5 RT-PCR profile of Glut-4 gene amplified from drug treated
L-6 cells (defatted HALH).
Fig.2 Alpha amylase inhibition activity of Quercetin and Rutin

Fig.6 Densitometric analysis of gene transcripts. The relative
level of Glut-4 gene expression is normalized to GAPDH (defatted
HALH). Values shown depicted in arbitrary units.

Fig.3 Alpha amylase inhibition activity of Acarbose
Table 1. Results of DPP-IV inhibition studies of HALE and HALH
Sl. No.

Name of drug

1

Ile-Pro-Ile

2

HALH
(defatted)

Test concentration. in
μg/ml
50.00
25.00
12.50
6.25
500.00
250.00
125.00
62.50
31.25

% Inhibition ± SD
86.83±0.50
75.29±2.25
71.90±2.40
48.69±4.58
15.83±8.20
06.05±3.31
0
0
0

IC50 in μg/ml
6.51

>500

n=3
IC50 values were above 500 μg/ml for defatted HALH samples. Defatted HALH exhibited 15.83% inhibition of DPP-IV activity at a
concentration of 500μg/ml.
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Table 2. In vitro glucose uptake studies of HALE and HALH on L-6 cell lines
Sl No
1
2
3
n=3

Name of the extract
HALE
HALH
Insulin

Test concentration (µg/ml)
1000
1000
1 IU/ml

% glucose uptake over control ± SD
14.0 ± 4.17
26.0 ± 5.22
131.50 ± 17.62

Table 4. RT PCR Glut-4 gene amplification data of defatted HALH
Test sample

Control

Treated concentration (500μg/ml)

Treated concentration (250μg/ml)

Standard

Regulation in terms of folds

1

1.15

1.09

1.52

Table 5 PPARγ upregulation details of HALH
Test sample

Control

Treated concentration (500μg/ml)

Treated concentration (250μg/ml)

Standard

Regulation in terms of folds

1

1.20

1.15

1.34

Inference

Inference

In this study the results show upregulation of Glut-4 gene
in test samples (treated) and standard when compared
with the control. The test sample of 500 and 250 μg/
ml concentrations were upregulated 0.15 folds and 0.09
folds, respectively compared to control. The standard was
upregulated 0.37 and 0.43 folds from treated concentration
of 500 and 250 μg/ml, respectively and 0.52 folds from
control.

In this study the results show upregulation of PPARγ gene
in test samples (Treated) and Standard, when compared with
the Control. The test sample of 500 conc. and 250 conc. is
0.20 folds and 0.15 folds upregulated respectively, compared
to control. The Standard is 0.14 and 0.19 folds upregulated
from treated of 500 and 250 conc. respectively and 0.34
folds from control.

Fig. 7 RT-PCR profile of PPARγ gene amplified by HALH treated
L6 cells.

DISCUSSION
In the alpha amylase inhibition studies performed, both
the extracts HALE and HALH were demonstrating IC50
values above 1000 μg/ml concentration. This is indicative
of the minimal antidiabetic activity effected by alpha
amylase inhibition by both the extracts. IC50 values of the
pure components quercetin and rutin were 931±9.28 μg/
ml (3.03 mM) and above 2000 μg/ml (3.2 mM) respectively.
Early reports2,3 of the presence of flavonoids apigenin,
kaempferol, quercetin and their glycosides can be correlated
here. In the year 2006, Tadeja et al,13 reported the alpha
amylase inhibitory action of quercetin, kaempferol and
apigenin and was reported again in the year 2013 by Orhan
et al,14. Thus, we can conclude that, the demonstrated
alpha amylase inhibition can be due to the above reported
phytoconstituents present in the extract.
If we consider the μM ratio, it can be seen that the efficiency
is almost equal for quercetin and rutin. The IC50 of quercetin
was 3.08 mM and that of rutin (Q-3-O-rutinoside) was 3.2
mM, an almost same value of molar mass. Thus, it can be
concluded that the effect were produced by quercetin, the
aglycone of rutin.

Fig. 8 Densitometric analysis of gene transcripts. The relative
level of PPARγ gene expression is normalized to GAPDH. Values
shown depict arbitrary units.
18
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On comparing to the alpha amylase inhibition action of
acarbose, the inhibition produced by both the extracts,
quercetin and rutin are less.
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In the DPP-IV activity inhibition evaluation, HALH exhibited
15.83% inhibition only at a concentration of 500 μg/ml.
This data is also indicative of minimum contribution to the
antidiabetic activity produced by HALH. The mechanism of
DPP-IV inhibitors is to increase incretin levels (GLP-1 and
GIP), which inhibit glucagon release, which in turn increases
insulin secretion and decreases blood glucose levels15. Early
report of DPP-IV inhibitory action of twenty one phenolics
can be correlated here16. Out of them, luteolin and apigenin
are the most potent. The minimum DPP-IV inhibitory
action demonstrated here can be correlated with the early
report of flavonoids and especially apigenin2. Thus, further
enrichment of flavonoid/phenolic content by purification of
HALH may improve the activity.
In the MTT assay, both extracts were showing CTC50 values
at a concentration above 1000 μg/ml. This can be correlated
to the observation of the first author about the interest of the
goats/sheep in the villages to eat this plant. The above result
indicates the nontoxic nature of the plant. The results of cell
line studies indicate the glucose uptake facilitation by both
the extracts and HALH treated cells demonstrated a better
activity among the two. HALH demonstrated 26.0±5.22%
of glucose uptake compared to the normal control.
In the evaluation of mechanism of action, upregulation of
Glut-4 gene was demonstrated by HALH and the standard
drug metformin treated cells. HALH at 500 and 250 μg/
ml concentrations upregulated Glut-4 genes 0.15 folds and
0.09 folds, respectively compared to the house keeping gene
(GAPDH) as the internal control. The standard upregulated
Glut-4 gene 0.52 fold is compared to normal control at a
concentration of 500 μg/ml. Glut-4 translocation facilitation
by apigenin17and Glut-4 activation by quercetin18 are already
reported. As the presence of apigenin, kaempferol, quercetin
and their glycosides such as rutin are reported, the above
gene translocation can be considered as an effect of the
above components.
Determination of expression of the receptor and possible
involvement in insulin action/resistance in skeletal muscle,
PPARγ mRNA abundance and its regulation by insulin were
quantified in muscle tissue and cultures using competitive
reverse transcription-polymerase chain reaction (RT-PCR),
Park K S19.
PPARγ agonists, regulating the expression
of several genes involved in the regulation of glucose, lipid
and protein metabolism and enhances the action of insulin
in insulin-sensitive tissue by increasing glucose uptake in

skeletal muscle and adipose tissue and decreasing hepatic
glucose production20.
In the year 2013, Annapurna et al, reported the effect of
apigenin on Glut-4 and PPARγ up regulation21. In addition
to that, Murase et al., reported the upregulation of PPARγ by
quercetin and gallic acid esters22.
The upregulation of PPARγ demonstrated in this
experiment can be correlated with the above all cited activity
contributions by the flavonoids quercetin and apigenin and
their glycosides.
CONCLUSION
In this study the acclaimed antidiabetic property of H.
arifolia was evaluated on its leaf extracts HALE and HALH.
Even though the alpha amylase inhibitory activity and
DPP-IV inhibitory activity results alone cannot explain the
antidiabetic action demonstrated by the alcoholic extract in
the animal studies reported by Nair et al7, we can find that the
above two enzyme inhibition methods are also contributing
towards the antidiabetic action. In the glucose uptake studies
performed on L-6 muscle cell lines, glucose uptake facilitation
by both the extracts was also demonstrated. In the evaluation
of mechanism for glucose uptake, upregulation of Glut-4
genes is clearly demonstrated. MTT assay result is indicative
of the non-toxic nature of the extract also. Thus, it can be
concluded that, the acclaimed antidiabetic property of H.
arifolia is true and the effect is produced by a combined effect
of enzyme inhibitions such as alpha amylase inhibition,
DPP-IV inhibition and also by glucose uptake facilitation
in L-6 muscle cell lines. The glucose uptake by L-6 muscle
cells is the most important property required for the normal
activities of human beings/animals. It is facilitated by this
extract and the extract is nontoxic as well. Hence, this plant
can be considered as antidiabetic. Further fractionation of
the extract, enrichment of the components in each fraction
and more specific studies will help in the identification
of a nontoxic, renewable, better and economically viable
antidiabetic agent.
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